Muscle relaxant study in asian volunteers – no cure, just data
NCT ID NCT07464535
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study gave 20 healthy Japanese and Chinese adults a single dose of TNX-102 SL (a cyclobenzaprine tablet placed under the tongue) to see how the drug moves through their bodies. Researchers compared two doses and checked safety. The goal was only to gather information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TNX-102 SL (cyclobenzaprine sublingual tablet)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Altasciences Clinical Los Angeles, Inc.
Cypress, California, 90630, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A two-session balance workout may cut fall risk in seniors
- Salty air: a new way to help lungs sweep themselves clean?
- First human test of SSGJ-626: will it be safe?
- Scientists to test how healthy bodies react to exercise in thin air
- Does stretching after weights change how your heart recovers?
- Could heart disease start outside the heart? new imaging study aims to find out